Merck & Co., Inc. (MRK)
NYSE: MRK · Real-Time Price · USD
117.65
-4.28 (-3.51%)
At close: Feb 9, 2026, 4:00 PM EST
117.43
-0.22 (-0.19%)
Pre-market: Feb 10, 2026, 8:41 AM EST
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
|---|
| 36.51B | 32.28B | | | | | | | | | | | | |
United States Revenue Growth | 13.11% | 13.33% | | | | | | | | | | | | |
Europe, Middle East and Africa Revenue | - | 14.04B | | | | | | | | | | | | |
Europe, Middle East and Africa Revenue Growth | - | 5.94% | | | | | | | | | | | | |
| - | 3.46B | | | | | | | | | | | | |
Latin America Revenue Growth | - | 12.09% | | | | | | | | | | | | |
| - | 5.49B | | | | | | | | | | | | |
| - | -19.23% | | | | | | | | | | | | |
Asia Pacific (other than China and Japan) Revenue | - | 3.06B | | | | | | | | | | | | |
Asia Pacific (other than China and Japan) Revenue Growth | - | -5.18% | | | | | | | | | | | | |
| - | 3.28B | | | | | | | | | | | | |
| - | 3.67% | | | | | | | | | | | | |
| - | 2.56B | | | | | | | | | | | | |
Other Geographic Revenue Growth | - | 21.63% | | | | | | | | | | | | |
| 28.50B | - | | | | | | | | | | | | |
| 65.01B | 64.17B | | | | | | | | | | | | |
| 1.31% | 6.74% | | | | | | | | | | | | |
Revenue
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
|---|
| 58.14B | 57.40B | | | | | | | | | | | | |
Pharmaceutical Revenue Growth | 1.29% | 7.12% | | | | | | | | | | | | |
| 6.35B | 5.88B | | | | | | | | | | | | |
Animal Health Revenue Growth | 8.12% | 4.48% | | | | | | | | | | | | |
| 515.00M | 891.00M | | | | | | | | | | | | |
Other Product Revenue Growth | -42.20% | -1.76% | | | | | | | | | | | | |
| 65.01B | 64.17B | | | | | | | | | | | | |
| 1.31% | 6.74% | | | | | | | | | | | | |
EBT
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
|---|
Pharmaceutical Segment Profit | - | 44.53B | | | | | | | | | | | | |
Pharmaceutical Segment Profit Growth | - | 14.54% | | | | | | | | | | | | |
Animal Health Segment Profit | - | 1.94B | | | | | | | | | | | | |
Animal Health Segment Profit Growth | - | 11.57% | | | | | | | | | | | | |
| - | -26.54B | | | | | | | | | | | | |
Updated Feb 3, 2026. Data Source:
Fiscal.ai.
